Trial intelligence / Profile preview

High-Dose Acetaminophen and Carmustine in Metastatic Melanoma

NCT00003346Phase 2Completed

Sponsor
Memorial Sloan Kettering Cancer Center
Start
Nov 1997
Primary completion
Feb 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acetaminophen in melanoma, sponsored by Memorial Sloan Kettering Cancer Center. Started Nov 1997; status: completed.

02

Drugs

acetaminophen
03

Conditions

melanoma

Beyond the preview

Go deeper on NCT00003346.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003346.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call